Lumicell

company

About

Lumicell is a biotechnology company that develops and markets image-guided cancer surgery solutions.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$0.99M
Industries
Biotechnology,Hardware,Health Care,Health Diagnostics,Medical
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

Lumicell is specializing in the field of image-guided cancer surgery. The company's technology illuminates cancer cells in the tumor cavity, enabling physicians to take action in real-time to improve patient outcomes. The company's lead product, consisting of a fluorescent optical contrast agent and a handheld illumination device, is currently under clinical investigation in patients undergoing breast cancer surgery. A planned pivotal study aims to evaluate the ability of the technology to reduce positive margin rates and reduce repeat surgeries while sparing healthy tissue. Lumicell technology is also being investigated in colorectal cancer, Barrett’s Esophagus, pancreatic cancer, and brain metastases. In clinical studies to date, no cancer has been missed and the safety profile of the optical contrast agent has been demonstrated.

Lumicell was founded in 2008 and is based in Newton, MA, USA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$0.99M
Lumicell has raised a total of $0.99M in funding over 2 rounds. Their latest funding was raised on Apr 10, 2012 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 10, 2012 Grant $0.99M 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Lumicell is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant